Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Posttransplant lymphoproliferative disorders

McAlister V, Grant D, Roy A, Yilmaz Z, Ghent C, Wall W. Posttransplant lymphoproliferative disorders in liver recipients treated with OKT3 or ALG induction immunosuppression. Transplant Proc 1993 25(1 Pt 2) 1400-1. [Pg.2401]

Lones MA, Shintaku IP, Weiss LM, et al. Posttransplant lymphoproliferative disorder in liver allograft biopsies a comparison of three methods for the demonstration of Epstein Barr virus. Hum Pathol. 1997 28 533-539. [Pg.76]

Pitman SD, Huang Q, Zuppan CW, et al. Hodgkin lymphomalike posttransplant lymphoproliferative disorder (HL-like PTLD) simulates monomorphic B-cell PTLD both clinically and pathologically. Am J Surg Pathol. 2006 30 470-476. [Pg.155]

BL, Burkitt lymphoma BLL, Burkitt-like lymphoma cHL, classical Hodgkin lymphoma IL, immunoblastic lymphoma LBL-B, lymphoblastic lymphoma precursor B-cell LBL-T, lymphoblastic lymphoma precursor T-cell LPL, lymphoplasmacytic lymphoma MM, multiple myeloma N, almost always negative PCLBL, primary cutaneous large B-cell lymphoma PEL, primary effusion lymphoma pHL, lymphocyte predominance Hodgkin lymphoma P-PTLD, polymorphic posttransplant lymphoproliferative disorders P-TCL, peripheral T-cell lymphoma PTLD, posttransplant lymphoproliferative disorders. [Pg.160]

Evans syndrome, refractory to immunosuppressive therapy Graft vs. host disease, chronic, steroid refractory Pemphigus vulgaris, severe Posttransplant lymphoproliferative disorder... [Pg.333]

Dolcetti, R. (2007) B lymphocytes and Epstein-Barr vims the lesson of posttransplant lymphoproliferative disorders. Autoimmunity Reviews, 7, 96-101. [Pg.196]

Hori T, Oike F, Hata K, Nishikiori M, Ogura Y, Ogawa K, Takada Y, Egawa H, Nguyen JH, Uemoto S. Hashi-moto s encephalopathy after interferon therapy for hepatitis C virus in adult liver transplant recipient accompanied by posttransplant lymphoproliferative disorder related to Epstein-Barr virus infection. Transpl Infect Dis 2010 12(4) 347-52. [Pg.596]

The posttransplant lymphoproliferative disorders (PTLD) are abnormal proliferations of lymphoid cells typically containing EBV that occurs in the setting of chronic immunosuppression needed for organ transplantation. The lymphoid proliferations have a variety of histologic, immunophenotypic, genotypic, and clinical features. Most are B-ceU lesions, but rarely there may be T-cell proliferations. [Pg.420]

Chen JM, Barr ML, Chadhum A, et al. Management of lymphoproliferative disorders after cardiac transplantation. Ann Thorac Surg 1993 56(3) 527-538. Nalesnik MA, Jaffe R, Starzl TE, et al. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 1988 133(1) 173-192. [Pg.427]

Brittinger WD, Walker G, Twittenhoff WD et al (1997) Vascular access for hemodialysis. Pediatr Nephrol 11 87-95 Bunchman TE (1995) Chronic dialysis in the infant less than 1 year of age. Pediatr Nephrol 9 S18-S22 Burney K, Bradley M, Buckley A et al (2006) Posttransplant lymphoproliferative disorder a pictorial review. Austra-las Radiol 50 412-418... [Pg.411]

Dodd GD 3rd, Ledesma-Medina J, Baron RL, Fuhrman CR (1992) Posttransplant lymphoproliferative disorder in-trathoracic manifestations. Radiology 184 65-69... [Pg.171]

See other pages where Posttransplant lymphoproliferative disorders is mentioned: [Pg.850]    [Pg.850]    [Pg.440]    [Pg.16]    [Pg.95]    [Pg.755]    [Pg.698]    [Pg.1475]    [Pg.1634]    [Pg.566]    [Pg.420]    [Pg.257]    [Pg.226]   
See also in sourсe #XX -- [ Pg.850 ]

See also in sourсe #XX -- [ Pg.1639 , Pg.2449 ]



SEARCH



Lymphoproliferative disorders

Posttransplant lymphoproliferative

© 2024 chempedia.info